- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02941900
Interest and Impact of Skin Cancer Genetic Testing
January 19, 2023 updated by: Memorial Sloan Kettering Cancer Center
PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS
The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing.
Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
53
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
MSK clinics
Description
Inclusion Criteria:
- 18 years of age or older
- English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages
- Prior history of stage 0, I or II NMSC as per EMR or clinical judgment
Exclusion Criteria:
- Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Non-melanoma skin cancers (NMSCs)
|
The website includes three educational modules about genetic testing with corresponding knowledge questions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
number of patients interested in MC1R testing
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jennifer Hay, PhD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
January 18, 2023
Study Completion (Actual)
January 18, 2023
Study Registration Dates
First Submitted
October 20, 2016
First Submitted That Met QC Criteria
October 20, 2016
First Posted (Estimate)
October 21, 2016
Study Record Updates
Last Update Posted (Actual)
January 20, 2023
Last Update Submitted That Met QC Criteria
January 19, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-1243
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-melanoma Skin Cancer (NMSC)
-
Massachusetts General HospitalCompletedNon-Melanoma Skin Cancer (NMSC)United States
-
Skin Analytics LimitedInnovate UKCompleted
-
Assistance Publique - Hôpitaux de ParisRecruitingSkin Cancer, Non-MelanomaFrance
-
Technische Universität DresdenCompletedNon-melanoma Skin CancerGermany
-
Assiut UniversityCompleted
-
Skin Analytics LimitedInnovate UKCompleted
-
Xoft, Inc.Enrolling by invitationNon-melanoma Skin CancerUnited States
-
University of Colorado, DenverWithdrawn
-
University of Alabama at BirminghamCompleted
Clinical Trials on MC1R genotyping
-
University of UtahCompletedMelanoma | Young AdultUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
University Hospital, RouenInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
Kyungpook National University HospitalCompletedAge-Related Macular DegenerationKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute; Duke University and other collaboratorsActive, not recruitingLeukemiaUnited States
-
Sohag UniversityNot yet recruiting
-
Sohag UniversityRecruitingType 2 Diabetes MellitusEgypt
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen UniversityRecruitingPancreatic Cancer | Pharmacokinetics | Gene PolymorphismsChina
-
Istituto Auxologico ItalianoRecruitingPapillary Thyroid CancerItaly
-
Boston UniversityActive, not recruiting